Email This Article

Headlines & Perspectives
AMAG's Feraheme Closer to Approval
By Adam Feuerstein
05/01/09 - 01:04 AM EDT
All outstanding issues pertaining to the manufacturing of Feraheme, AMAG Pharmaceuticals' iron replacement therapy, have been settled to the satisfaction of the Food and Drug Administration.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,308.26 1,096.07 2,180.05 34.87
Oil *
73.22
DOWN
132.86
DOWN
13.11
DOWN
26.86
DOWN
1.09
10 Yr
3.49%
SPDR Gold
107.34
-1.27%
-1.18%
-1.22%
-3.03%
Data delayed 20 minutes

More From TheStreet

Latest Headlines

Brokerage Partners